Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
ap-101 (2 trials)
Amyotrophic Lateral Sclerosis (Phase 1)
Motor Neuron Disease (Phase 1)
Sclerosis (Phase 1)
Trials (2 total)
Trial APIs (1 total)